Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT)

Neuroendocrinology Letters

Volumn 30, Issue 2, 2009, Pages 209-214

  Czarnywojtek, Agata ^a   Czepczynski, Rafal ^a   Ruchala, Marek ^a   Waśko, Ryszard ^a   Zgorzalewicz Stachowiak, Magorzata ^a   Szczepanek, Ewelina ^a   Zamyslowska, Hanna ^a   Bartkowiak, Zuzanna ^a   Florek, Ewa ^a   Sowinski, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Amiodarone induced thyrotoxicosis; Low radioactive iodine uptake; Radioiodine therapy

Indexed keywords

AMIODARONE; ANTITHYROID PEROXIDASE AUTOANTIBODY; ANTITHYROID STIMULATING HORMONE RECEPTOR AUTOANTIBODY; AUTOANTIBODY; LIOTHYRONINE; RADIOACTIVE IODINE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEART DISEASE; HUMAN; MALE; THYROID FUNCTION TEST; THYROID SCINTISCANNING; THYROTOXICOSIS;

EID: 70349308401     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E (1996). Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results from a prospective study. J Clin Endocrinol Metab. 81: 2930-2933. (Pubitemid 26323888)
2. Bartalena L, Bogazzi F, Martino E (2002). Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge. Clin Endocrinol (Oxf) 56:23-24. (Pubitemid 34107317)
3. Bartalena L, Brogioni S, Grasso L, Rago T, Vitti P & Martino E (1994). Interleukin-6: a marker of thyroid-destructive processes? J Clin Endocrinol Metab. 79: 1424-1427.
4. Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A, et al (2004). Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol (Oxf) 61: 494-502. (Pubitemid 39388489)
5. Basaria S & Cooper DS (2005). Amiodarone and the thyroid. Am J Med. 118: 706-714.
6. Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E (2001). The various effects of amiodarone on thyroid hormone. Thyroid. 11: 511-519 (Pubitemid 32494600)
7. Bogazzi F, Miccoli P, Berti P, Cosci C, Brogioni S, Aghini-Lombardi F, et al (2002) Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone induced thyrotoxicosis. Surgery. 132: 1114-1118. (Pubitemid 36026963)
8. Bonnyns M, Sterling I, Renard M, Bernard R, Demaret B, Bourdoux P (1989) Dexamethasone treatment of amiodarone-induced thyrotoxicosis (AIT) with or without persistent administration of the drug. Acta Cardiol 44: 235-243. (Pubitemid 19179338)
9. Broussolle C, Ducottet X, Martin C, Barbier Y, Bornet H, Noel G, et al (1989). Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis. Comparison of two groups of patients with apparently normal thyroid glands. J Endocrinol Invest 12: 37-42. (Pubitemid 19060729)
10. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, Kuch J, Nartowicz E, Smielak-Korombel J, et al (1992). Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol 20: 1056-1062.
11. Chopra IJ, Baber K (2001). Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism. J Clin Endocrinol Metab. 86: 4707-4710. (Pubitemid 33020509)
12. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, et al (1999). Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab. 84: 90-97. (Pubitemid 29036685)
13. Daniels GH (2001). Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 86: 3-8.
14. Eaton SEM, Euinton HA, Newman CM, Weetman AP & Bennet WM (2002). Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol. 56: 33-38.
15. Farwell AP, Abend SL, Huang SKS, Patwardhan NA, Braverman LE (1990). Thyroidectomy for amiodarone-induced throtoxicosis. J Am Med Assoc. 263: 1526-1528.
16. Florek E, Piekoszewski W, Wrzosek J (2003). Relationship between the level and time of exposure to tobacco smoke and urine nicotine and cotinine concentration. Pol J Pharmacol. 55: 97-102. (Pubitemid 36411124)
17. Harjai KJ, Licata AA (1997). Effects of amiodarone on thyroid function. Ann Intern Med. 126: 64-73.
18. Hermida JS, Jarry G, Tcheng E, Moullart V, Arlot S, Rey JL, et al (2004a). Radioiodine ablation of the thyroid to allow the reintroduction of amiodarone treatment in patients with a prior history of amiodarone-induced thyrotoxicosis. Am J Med. Mar. 116: 345-348
19. Hermida JS, Jarry G, Tcheng E, Moullart V, Arlot S, Rey JL, et al (2004b). Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131. Arch Mal Coeur Vaiss. 97: 207-213
20. Hermida JS, Tcheng E, Jarry G, Moullart V, Arlot S, Rey JL, et al (2004c). Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias. Europace. 6: 169-174
21. Iskandar SB, Jordan RM, Peris AN (2004). Treating amiodaroneinduced thyrotoxicosis with radioactive iodine. Tenn Med. 97: 408-410
22. Kennedy RL, Griffiths H, Gray TA (1989). Amiodarone and the thyroid. Clin Chem. 35: 1882-1887.
23. Latini R, Tognoni G, Kates RE (1984). Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet. 9: 136-156.
24. Leger AF, Fragu P, Rougier P, Laurent MF, Tubiana M, Savoie JC (1983). Thyroid iodine content measured by x-ray fluorescence in amiodarone-induced thyrotoxicosis: concise communication. J Nucl Med. 24: 582-585. (Pubitemid 14131984)
25. Lombardi A, Martino E, Braverman LE (1990). Amiodarone and the thyroid. Thyroid Today. 13: 1-7.
26. Martino E, Aghjini F, Mariotti S, Bartalena L, Braverman L, Pinchera A (1987). Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res. 26: 158-171. (Pubitemid 17071710)
27. Martino E, Bartalena L, Bogazzi F, Braverman LE (2001). Amiodarone and the thyroid. Endocr Rev 22: 240-254.
28. Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, et al (1984). Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 101: 28-34. (Pubitemid 14088063)
29. McEvoy GK (2000). AHFS drug information 2000. Bethesda, MD: American Society of Health-System Pharmacists.
30. Meurisse M, Hamoir E, D'Silva M, Joris J, Henne G (1993). Amiodarone-induced thyrotoxicosis: is there a place for surgery? World J Surg. 17: 622-626.
31. Pearce EN, Bogazzi F, Martino E, Brogioni S, Pardini E, Pellegrini G, et al (2003). The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid. 13: 643-648. (Pubitemid 36993559)
32. Piga M, Cocco MC, Serra A, Loy M, Boi F & Mariotti S (2008). The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Eur J Endocrinol. 159: 423-429.
33. Podrid PJ. 1995 Amiodarone: reevaluation of an old drug. Ann Intern Med. 122: 689-700.
34. Reichert LJ, de Rooy HA (1989). Treatment of amiodarone induced hyperthyroidism with potassium Perchlorate and methimazole during amiodarone treatment. Br Med J. 298: 1547-1548.
35. Reiffel JA, Estes III NA, Waldo AL, Prystowsky EN, Di Bianco R (1994). A consensus report on antiarrhythmic drug use. Clin Cardiol 17: 103-116.
36. Roti E, Minelli R, Gardini E, Bianconi L, Braverman LE (1993). Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone: a possible consequence of a destructive process in the thyroid. Arch Intern Med. 153: 886-892. (Pubitemid 23118029)
37. Simon C, Schlienger JL, Chefran J, Studer H (1985). Efficacitè de la dexamethasone dans le traitement de l'hyperthyroidie à l'amiodarone. Presse Med. 13: 2767-2770.
38. Singh SN, Fletcher RD, Fisher RG, Singh BN, Lewis HD, Deedwania PC, et al (1995). Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. Survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med. 333: 77-82.
39. Tanda ML, Bogazzi F, Martino E & Bartalena L (2008). Amiodarone induced thyrotoxicosis: something new to refine the initial diagnosis? Eur J Endocrinol 159: 359-361.
40. Wiersinga WM (1997). Amiodarone and the thyroid. In: Weetman AP, Grossman A, eds. Pharmacotherapeutics of the thyroid gland. Berlin: Springer Verlag; 225-287.
41. Wimpfheimer C, Staubli M, Schadelin J, Studer H (1982). Prednisone in amiodarone-induced thyrotoxicosis. Br Med J 284: 1835-1836.